Skip to Content
Merck

524629

Phosphatase Inhibitor Cocktail V

50X, liquid, for the inhibition of serine/threonine and tyrosine phosphatase

Synonym(s):

Phosphatase Inhibitor Mix Set V, Phosphatase inhibitor

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

UNSPSC Code:
12352200
NACRES:
NA.77
Form:
liquid
Solubility:
water: soluble
Storage temp.:
−20°C
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Phosphatase Inhibitor Cocktail Set V, 50X, Phosphatase Inhibitor Cocktail Set V is a 50X cocktail of four serine/threonine and tyrosine phosphatase inhibitors.

form

liquid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze
protect from light

solubility

water: soluble

shipped in

wet ice

storage temp.

−20°C

Application

Phosphatase Inhibitor Cocktail Set V, 50X has been used:
  • as a supplement in the lysis buffer to dissociate metabolically activated one (MMe) bone marrow macrophages (BMDMs) for Western blot
  • in radio-immunoprecipitation assay (RIPA) modified buffer to incubate cultured human umbilical vein endothelial cells (HUVECs) for western blot
  • in lysis buffer to lyse cultured HUVECs for immunoprecipitation
  • in wash buffer to wash the protein complexes
  • as a component in 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES) buffer to homogenize J774 cells to assess the effect of lipopolysaccharides (LPS) incubation on cytosolic phospholipase A2 (cPLA2) activity

Biochem/physiol Actions

Protein phosphorylation and dephosphorylation play a crucial role in signal transduction, controlling various cellular processes such as cell division, proliferation, and apoptosis. Protein kinases add a phosphate group to specific serine, threonine, or tyrosine residues, which alters the protein′s conformation and its ability to interact with ligands. Protein phosphatases then remove the phosphate group, restoring the protein to its original dephosphorylated state. When extracting phosphorylated proteins from cell and tissue lysates, it is of utmost importance to preserve their phosphorylation state.

Disclaimer

Toxicity: Toxic (F)

Features and Benefits

  • Convenient: formulations are ready-to-use, making them easy to use.
  • Consistent: high-quality formulations ensure reliable and reproducible performance.
  • Flexible: the cocktails are designed to target different categories of phosphatases, offering versatility in experimentation.

General description

A cocktail of four phosphatase inhibitors for the inhibition of both serine/threonine and protein tyrosine phosphatases. Available as 1 ml or as a set of five 1 ml vials.

Other Notes

Each vial contains 1 ml of aqueous solution with the following components:
  • 250 mM Sodium Fluoride
  • 50 mM ß-Glycerophosphate (Cat. No. 35675)
  • 50 mM Sodium Pyrophosphate Decahydrate
  • 50 mM Sodium Orthovanadate      

Physical form

In H₂O.

Preparation Note

Following initial thaw, aliquot and freeze (-20°C) for long-term storage. Dilute 1:50 just prior to use.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2

Storage Class

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Endothelial EphB4 maintains vascular integrity and transport function in adult heart
Guillermo L, et al.
eLife, 8, e45863-e45863 (2019)
Lysophosphatidylinositols in inflammation and macrophage activation: altered levels and anti-inflammatory effects
Masquelier J, et al.
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1863(12), 1458-1468 (2018)
Houhong Zhou et al.
Frontiers in pharmacology, 13, 1050774-1050774 (2022-11-18)
A large proportion of bladder cancer (BLCA) patients suffer from malignant progression to life-threatening muscle-invasive bladder cancer (MIBC). Inflammation is a critical event in cancer development, but little is known about the role of inflammation in BLCA. In this study
Kévin Monceaux et al.
International journal of molecular sciences, 23(12) (2022-06-25)
Disturbances in Endoplasmic Reticulum (ER) homeostasis induce ER stress, which has been involved in the development and progression of various heart diseases, including arrhythmias, cardiac hypertrophy, ischemic heart diseases, dilated cardiomyopathy, and heart failure. A mild-to-moderate ER stress is considered
Yu-Ra Choi et al.
Cancers, 14(6) (2022-03-26)
Prediction of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) remains challenging. Thus, we investigated whether resistant cancer cells that expand shortly after EGFR-TKI treatment would eventually cause the resistant phenotype. We generated two EGFR-mutant lung cancer cell

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service